A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting
Clinical trial NCT03083821 · COMPLETED
Trial details
- NCT number
- NCT03083821
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-16
- Primary completion
- 2017-12-19
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.